Tilray | TRLY - Current Liabilities

Stock Price
9.48
Daily Change
-0.03 -0.32%
Monthly
-7.60%
Yearly
977.27%
Q1 Forecast
9.24

Tilray reported $280.3M in Current Liabilities for its fiscal quarter ending in March of 2025.





Current Liabilities Change Date
Acasti Pharma USD 1.24M 1.08M Sep/2025
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Aurora Cannabis CAD 124.12M 32.76M Sep/2025
Avita Medical AUD 62.68M 77K Dec/2025
Canopy Growth CAD 81.1M 17.56M Sep/2025
Cronos Group USD 48.19M 7.12M Dec/2025
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Divis Laboratories Ltd INR 17.28B 2.76B Sep/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Moderna USD 1.99B 306M Dec/2025
Organigram Holdings CAD 126.16M 18.88M Sep/2025
Organon & Co USD 2.68B 117M Sep/2025
Revvity USD 1.33B 108.5M Dec/2025
Tectonic Therapeutic USD 9.37M 1.99M Sep/2025
Tilray USD 280.3M 18.13M Mar/2025
Viatris USD 7.09B 269.8M Dec/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025